Saminvest AB
Marianne Dicander Alexandersson serves as Chairman at Occlutech since April 2021, leading a company recognized globally for its innovations in structural heart disease. Additionally, Marianne holds board positions at Linc AB, Saminvest AB, and Sahlgrenska Science Park, contributing to the oversight of investments and the development of venture capital in the Life Science sector. Previous board roles include Membership at Praktikertjänst AB and Skandia, and board memberships at Enzymatica AB, Recipharm, and Camurus. In these roles, Marianne has been involved in various committees, including audit and remuneration committees, ensuring sound governance and strategic direction across organizations in healthcare and pharmaceuticals.
This person is not in any teams
This person is not in any offices
Saminvest AB
Saminvest är ett riskkapitalbolag, bildat av staten 2016. Saminvest arbetar aktivt för etableringen av nya venture capital-fonder (”VC”) med tillräckliga kvaliteter och långsiktighet att kunna utveckla den svenska riskkapitalmarknaden. Detta för att flera innovativa och snabbväxande företag ska få tillgång till såväl kapital som ägarkompetens. Totalt förvaltar Saminvest tillgångar på cirka sex miljarder kronor.